PlainRecalls
FDA Drug Low Class III Terminated

Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04

Reported: May 10, 2017 Initiated: December 27, 2016 #D-0692-2017

Product Description

Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04

Reason for Recall

Superpotent Drug; out of specification results for assay (manufacturer)

Details

Recalling Firm
The Harvard Drug Group
Units Affected
36,990 tablets
Distribution
Nationwide and PR
Location
Livonia, MI

Frequently Asked Questions

What product was recalled?
Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04. Recalled by The Harvard Drug Group. Units affected: 36,990 tablets.
Why was this product recalled?
Superpotent Drug; out of specification results for assay (manufacturer)
Which agency issued this recall?
This recall was issued by the FDA Drug on May 10, 2017. Severity: Low. Recall number: D-0692-2017.